Then Professor P C Elwood (Director, 'MRC Epidemiology Research Unit, Cardiff) presented some salient facts about iron supplementation. The practice in certain parts of China of increasing the consumption of eggs as a treatment for iron deficiency turned out to be an unhelpful approach, as it appears that the iron in eggs, although plentiful, is not biologically available. Indeed, studies described by Professor Elwood showed that eggs also greatly reduce the absorption of iron from other foods in the diet. The audience also learnt of the pitfalls of iron fortification of bread in the UK, and Professor Elwood finally questioned the desirability of iron supplementation to treat asymptomatic iron deficiency. He pointed out that whilst it was easy enough to introduce extra iron into food, it was difficult to evaluate the benefits or disadvantages. Finally, Dr B Wharton (Birmingham) drew our attention to work indicating that 'asymptomatic' iron deficiency in childhood may be associated with impaired cognitive function, which may be reversed after iron supplementation. It was fitting that the first day should conclude with Professor Tom Stapleton's Presidential Address entitled 'The youth of the world: have they lost their way?' A paper on idiopathic thrombocytopenic purpura (Dr J Li and Professor L Wang, Wuhan, China) was followed by.a very lucid report of recent trends in child health and survival in Zimbabwe (Dr F K Nkrumah and Dr K J Nathoo, Harare). A provocative presentation on factors influencing intelligence and physical development (Professor Z Gu, Xinjiang, China) was followed by reports on perinatal care (Dr H Ye, Beijing, China), follow up of premature infants (Dr Y Lu, General Hospital of the Air Force, China), and haemoglobinopathies in Sichuan (Dr Y Geng and Dr J Zhang). A paper on how to design hospitals in developing countries was given by Mr M Wells (Medical Building Design Unit, Department of Epidemiology and Community Medicine, University of Bristol), and this was accompanied by an excellent set of posters. Mr Wells described the process of planning and design, and he had some pertinent observations to make about the layout of consulting rooms and paediatric wards.
Early in 1986, a team of five professors of genetics from the UK visited China, and the meeting closed with short papers by Professors K M Laurence, N Nevin. D Roberts and R Harris describing the visit to Beijing and Shanghai. It appeared that the overall incidence of congenital malformations in China was similar to that of the UK, although it was pointed out that certain genetic disorders such as cystic fibrosis, galactosaemia, coeliac disease and Huntington's chorea are almost unknown in China. Professor Roberts pointed out the problems of a country whose population (1015 million) comprises one-quarter of the world's population, and whose numbers were constant between 1840 and 1940 and have doubled since then. He described the proposed eugenic law, which would prohibit marriage or reproduction in the case of certain genetic or psychiatric conditions. The similarity between the proposed law and the situation obtaining in Germany not so long ago was pointed out, and Professors Roberts and Harris both suggested an alternative of comprehensive genetic services, thus avoiding the need to infringe an individual's right to choose.
One of the strongest impressions of this remarkable meeting was Princess Anne's dedication to the problems of developing countries. After an overnight flight from Montreal she had arrived in London at 8.45 am, by which time most would be flagging, but she came to the RSM in time for the start of the meeting at 10.00am. Her lively and well informed comments typified the outstanding contribution that the Princess is making in the field ofchild health and welfare worldwide. Some of her interest has rubbed off on those around her. Over lunch we met a police inspector, assigned to the Princess for the last five years, who must, I imagine, be about the only policeman in the UK with whom one could discuss primary health care and vaccination problems in the Gambia! He complained that others had stolen his thunder and went on, as one knew he would, to set the table on a roar. Sir Harry, greatly moved, always a master orator, was almost unhorsed by this unique occasion but he replied to them all.
One of his skills deserves special mention. Having been a child patient himselfhe never forgot the dread that little children have of doctors. He cared for very many children -some with bone and joint tuberculosis, some the victims of trauma and some with congenital deformities. At winning their trust and cooperation he had no peer, and generations of crippled children remember him with gratitude and affection.
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Medico-Pharmaceutical Forum
On 9 June 1986 the Medico-Pharmaceutical Forum was very pleased to move into a new office on the third floor of the recently refurbished part of the Royal Society of Medicine. It shares its office with The Association of Medical Advisers in the Pharmaceutical Industry (AMAPI). Mrs Jacqueline Wase· Bailey, who has for many years served AMAPI so well, will now look after the interests of both groups and their membership.
The Medico-Pharmaceutical Forum was set up in 1968 as a result of joint discussions with the Association of the British Pharmaceutical Industry (ABPI) and the Royal Colleges and major medical societies in England and Scotland. The Royal Society of Medicine, and in particular their recently retired Executive Director, Mr RT Hewitt, played a major part in creating the Forum and it is therefore most appropriate that we should now be functioning out of that learned Society. The aims of the Medico-Pharmaceutical Forum are:
(1) To consider matters of joint interest to the medical profession and the pharmaceutical industry.
(2) To undertake, sponsor or promote studies of problems of mutual interest. (3) To make recommendations where appropriate.
To this end it formed a Statutory Body composed of representatives of the Colleges and Societies (currently 13) and 13 representatives appointed by ABPI. This Statutory Body meets twice a year in June and December to decide on Forum policy and has as its officers a Chairman, a Vice-Chairman, an Immediate Past Chairman, an Honorary Secretary and an Honorary Treasurer. These posts are shared between the academic representation and those representing the pharmaceutical industry. In addition an Executive Committee is appointed which meets four times a year in January, April, July and October to organize the programme of activities. This Committee comprises the officers and four ordinary members from academia and four from the ABPI.
